142 related articles for article (PubMed ID: 38510454)
1. Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors.
Kim YS; Kim A; Lee YS
Front Med (Lausanne); 2024; 11():1342184. PubMed ID: 38510454
[TBL] [Abstract][Full Text] [Related]
2. Decentralized clinical trials (DCTs): A few ethical considerations.
Petrini C; Mannelli C; Riva L; Gainotti S; Gussoni G
Front Public Health; 2022; 10():1081150. PubMed ID: 36590004
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities for sponsors in conducting clinical trials during a pandemic.
Davis S; Pai S
Perspect Clin Res; 2020; 11(3):115-120. PubMed ID: 33033700
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Financial Value of Decentralized Clinical Trials.
DiMasi JA; Smith Z; Oakley-Girvan I; Mackinnon A; Costello M; Tenaerts P; Getz KA
Ther Innov Regul Sci; 2023 Mar; 57(2):209-219. PubMed ID: 36104654
[TBL] [Abstract][Full Text] [Related]
5. Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality.
Unger JM; Stires H; Levit LA; Stewart M; McKelvey BA; Canin B; Dressler E; Flaherty K; Fredette P; Jones L; McCann P; Miller T; Onitilo AA; Palmieri F; Patel T; Paul R; Smith GL; Bruinooge SS; Garrett-Mayer E; Lei XJ; Alva A; Schenkel C
JCO Oncol Pract; 2023 Oct; 19(10):907-916. PubMed ID: 37643386
[TBL] [Abstract][Full Text] [Related]
6. Dutch public health professionals' perspectives and needs regarding citizen involvement in COVID-19 contact tracing through digital support tools: an exploratory qualitative study.
Helms YB; Stein ML; Hamdiui N; van der Meer A; Baron R; Eilers R; Crutzen R; Kretzschmar MEE; Timen A
BMC Health Serv Res; 2022 Nov; 22(1):1378. PubMed ID: 36403008
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.
Shimizu T; Kim DW; Loong HH; Lin CC; Ng MC; Yamamoto N; Ma B; Tan DS
Asia Pac J Clin Oncol; 2021 Aug; 17(4):388-395. PubMed ID: 33502085
[TBL] [Abstract][Full Text] [Related]
8. Leveraging Decentralized Clinical Trial Management Systems (dCTMS) to Advance Science: Exploring Challenges Related to the Diffusion of Innovation and Its Execution.
Rao RK
Blockchain Healthc Today; 2024; 7():. PubMed ID: 38715764
[TBL] [Abstract][Full Text] [Related]
9. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
Jeon J; Kim H; Yu KS
J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and challenges for decentralised clinical trials in sub-Saharan Africa: a qualitative study.
Nebie EI; Sawadogo HN; van Eeuwijk P; Signorell A; Reus E; Utzinger J; Burri C
BMJ Open; 2023 Sep; 13(9):e075903. PubMed ID: 37739467
[TBL] [Abstract][Full Text] [Related]
11. Decentralized Clinical Trials in the Development of Drugs and Biological Products.
Robinson R; Sacks L
Ther Innov Regul Sci; 2024 Feb; ():. PubMed ID: 38305983
[TBL] [Abstract][Full Text] [Related]
12. Quantifying Site Burden to Optimize Protocol Performance.
Florez M; Smith Z; Olah Z; Martin M; Getz K
Ther Innov Regul Sci; 2024 Mar; 58(2):347-356. PubMed ID: 38191957
[TBL] [Abstract][Full Text] [Related]
13. Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment.
Betcheva L; Kim JY; Erhun F; Oraiopoulos N; Getz K
Ther Innov Regul Sci; 2023 Sep; 57(5):1081-1098. PubMed ID: 37389795
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 site readiness initiative: Building clinical trial capacity for vaccine efficacy trials in Latin America in response to the pandemic.
Ann Costa Clemens S; Keiko Sekine A; Tovar-Moll F; Clemens R
Vaccine X; 2022 Dec; 12():100238. PubMed ID: 36407818
[TBL] [Abstract][Full Text] [Related]
15. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.
Apostolaros M; Babaian D; Corneli A; Forrest A; Hamre G; Hewett J; Podolsky L; Popat V; Randall P
Ther Innov Regul Sci; 2020 Jul; 54(4):779-787. PubMed ID: 32557302
[TBL] [Abstract][Full Text] [Related]
16. Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.
Lorenc A; Rooshenas L; Conefrey C; Wade J; Farrar N; Mills N; Paramasivan S; Realpe A; Jepson M
Trials; 2023 Jun; 24(1):424. PubMed ID: 37349850
[TBL] [Abstract][Full Text] [Related]
17. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
[TBL] [Abstract][Full Text] [Related]
18. Conducting dermatology clinical trials during the COVID-19 pandemic.
Sheriff T; Dickenson-Panas H; Murrell DF
Clin Dermatol; 2021; 39(1):104-106. PubMed ID: 33972036
[TBL] [Abstract][Full Text] [Related]
19. Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective.
de Jong AJ; van Rijssel TI; Zuidgeest MGP; van Thiel GJMW; Askin S; Fons-MartÃnez J; De Smedt T; de Boer A; Santa-Ana-Tellez Y; Gardarsdottir H;
Clin Pharmacol Ther; 2022 Aug; 112(2):344-352. PubMed ID: 35488483
[TBL] [Abstract][Full Text] [Related]
20. Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review.
van Rijssel TI; de Jong AJ; Santa-Ana-Tellez Y; Boeckhout M; Zuidgeest MGP; van Thiel GJMW;
Drug Discov Today; 2022 Oct; 27(10):103326. PubMed ID: 35870693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
